![Ehong Gu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ehong Gu
Financieel Directeur/CFO bij
LIANMEDICAL
Vermogen: - $ op 31-08-2026
Profiel
Ehong Gu is currently the Chief Financial & Accounting Officer at LianBio.
Previously, she worked as the Assistant Vice President-Finance at CStone Pharmaceuticals Co. Ltd. from 2019 to 2021.
She holds an MBA from Rotman School of Management and an undergraduate degree from Shanghai University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
LIANBIO -.--% | 19-12-2023 | 0 ( -.--% ) | - $ | 31-08-2026 |
Actieve functies van Ehong Gu
| Bedrijven | Functie | Begin |
|---|---|---|
| LIANMEDICAL | Financieel Directeur/CFO | 19-12-2023 |
Eerdere bekende functies van Ehong Gu
| Bedrijven | Functie | Einde |
|---|---|---|
| CSTONE PHARMACEUTICALS | Corporate Officer/Principal | 01-01-2021 |
Opleiding van Ehong Gu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
29
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Rotman School of Management
 Rotman School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai University
 Shanghai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CStone Pharmaceuticals Co. Ltd.
 CStone Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatments for oncology, cardiovascular diseases, rheumatoid arthritis, hematology and autoimmune diseases | Health Technology |
LianBio
 LianBio BiotechnologyHealth Technology Operates as a biotechnology company focused on bringing paradigm-shifting medicines to patients | Health Technology |
